Retour sur lavenir.net
   BIOTALYS 1.998 € (+2,46 %)     D'IETEREN GROUP 178.600 € (-2,03 %)     AGEAS 77.500 € (-1,27 %)     SOFINA 267.600 € (-1,98 %)     ACKERMANS V.HAAREN 268.000 € (-0,30 %)     LOTUS BAKERIES 14 060.000 € (-0,14 %)     BPOST 0.885 € (-23,31 %)     KBC 117.400 € (+0,30 %)     DEME GROUP 164.200 € (-2,15 %)     ARGENX SE 815.800 € (+0,02 %)     CIE BOIS SAUVAGE 278.000 € (-1,42 %)     RECTICEL 12.360 € (+0,65 %)     AB INBEV 75.700 € (+0,05 %)     MELEXIS 53.400 € (+1,71 %)     SOLVAY 24.360 € (-0,73 %)     ONWARD MEDICAL 1.780 € (-0,89 %)     MONTEA 69.400 € (+1,17 %)     VAN DE VELDE 29.400 € (-0,34 %)     WDP 19.400 € (0,00 %)     ASCENCIO 52.900 € (-0,94 %)     TITAN S.A. 45.540 € (-0,83 %)     VIOHALCO 14.880 € (+3,33 %)     UCB 290.900 € (+0,24 %)     MATERIALISE 6.100 € (-3,94 %)     DECEUNINCK 2.425 € (-1,22 %)     AEDIFICA 65.650 € (+0,84 %)     ELIA GROUP 134.000 € (+0,30 %)     ORANGE BELGIUM 22.200 € (-0,45 %)     ACCENTIS 0.027 € (+3,92 %)     SHURGARD 25.550 € (+0,20 %)     KINEPOLIS GROUP 49.350 € (-2,28 %)     VGP 65.500 € (-1,50 %)     SYENSQO 76.700 € (-2,91 %)     BANQUP GROUP 0.850 € (-5,56 %)     AZELIS GROUP 11.750 € (-1,67 %)     BREDERODE 100.800 € (-0,79 %)     JENSEN-GROUP 74.400 € (+0,54 %)     NYXOAH 0.754 € (-1,57 %)     VASTNED 27.350 € (-0,73 %)     CMB.TECH 14.920 € (-1,97 %)     ENERGYVISION 17.180 € (-1,26 %)     UMICORE 18.470 € (-0,91 %)     BEKAERT 40.000 € (-1,60 %)     TESSENDERLO 17.620 € (-1,78 %)     TINC 10.400 € (-0,38 %)     FAGRON 24.200 € (-0,82 %)     RETAIL ESTATES 63.500 € (+0,47 %)     ONTEX GROUP 1.504 € (+1,08 %)     KBC ANCORA 94.200 € (+0,21 %)     COLRUYT 36.600 € (-1,03 %)     ECONOCOM GROUP 1.540 € (-2,53 %)     BELYSSE GROUP 0.350 € (-2,78 %)     CARE PROPERTY INV. 12.680 € (-0,31 %)     SOLVAC 86.000 € (-1,15 %)     WERELDHAVE BELGIUM 51.400 € (+1,98 %)     PROXIMUS 6.330 € (-0,71 %)     IBA 16.360 € (-1,56 %)     CENERGY 21.160 € (-0,09 %)     EVS 18.000 € (-0,99 %)     GIMV 49.350 € (0,00 %)  
   CSG 13.032 € (-3,85 %)     AKZO NOBEL 62.900 € (+0,51 %)     AVANTIUM(SUB) 0.250 € (-55,36 %)     PHILIPS KON 27.330 € (-0,65 %)     BE SEMICONDUCTOR 143.400 € (+1,77 %)     ASML HOLDING 1 283.600 € (+2,69 %)     AIR LIQUIDE 187.780 € (-1,02 %)     CELLECTIS 1.005 € (-4,10 %)     WOLTERS KLUWER 90.080 € (-2,53 %)     ADYEN 901.200 € (+0,97 %)     JACQUES BOGART 1.310 € (+15,93 %)     SAFRAN 295.500 € (-0,71 %)     BOUYGUES 42.290 € (-1,86 %)     STELLANTIS NV 4.019 € (+1,39 %)     VINCI 111.600 € (-1,20 %)     LVMH 408.750 € (-2,36 %)     ALPES (COMPAGNIE) 19.500 € (+1,46 %)     HERIGE 18.450 € (+2,22 %)     SAINT GOBAIN 74.100 € (-0,46 %)     AIRBUS 196.400 € (-1,25 %)     BUREAU VERITAS 29.950 € (-0,89 %)     ING GROEP N.V. 28.720 € (-1,73 %)     OCI 4.090 € (-0,29 %)     DSM FIRMENICH AG 109.800 € (-3,09 %)     RELX 36.180 € (-2,22 %)     BAM GROEP KON 12.610 € (+0,56 %)     FUGRO 8.480 € (-2,19 %)     X-FAB 4.840 € (+2,63 %)     SOITEC 94.340 € (+2,95 %)     AXA 44.680 € (-2,25 %)     SHELL PLC 44.740 € (-1,54 %)     MICHELIN 33.200 € (-0,42 %)     ABN AMRO BANK N.V. 41.000 € (-0,94 %)     ESSILORLUXOTTICA 193.800 € (+0,96 %)     IPSEN 158.700 € (-0,44 %)     HAL TRUST 169.600 € (-1,17 %)     NRJ GROUP 5.860 € (-2,33 %)     HAVAS 17.850 € (-2,19 %)     EURONEXT 170.000 € (-2,47 %)     SAMSE 113.500 € (-0,44 %)     REXEL 34.450 € (+0,17 %)     CAPGEMINI 126.900 € (-2,76 %)     LAKEFRONT BIOTHER. 29.620 € (-1,92 %)     ENGIE 24.200 € (+0,79 %)     ASM INTERNATIONAL 651.000 € (+2,39 %)     SARTORIUS STED BIO 225.800 € (+0,71 %)     SIDETRADE 204.500 € (+0,74 %)     ADP 117.100 € (-0,59 %)     ABIVAX 77.150 € (-0,64 %)     UNILEVER 59.310 € (-1,79 %)     CREDIT AGRICOLE 15.840 € (+0,38 %)     PERNOD RICARD 71.140 € (-0,73 %)     STMICROELECTRONICS 37.635 € (+1,54 %)     IMERYS 25.400 € (-1,17 %)     FLEURY MICHON 23.900 € (+0,84 %)     PLANISWARE 24.900 € (-1,39 %)     EUROFINS SCIENT. 88.640 € (-0,45 %)     EURAZEO 49.380 € (-2,22 %)     ALTAREA 74.100 € (-0,94 %)     TIKEHAU CAPITAL 16.720 € (-0,24 %)  
ARKEMA
AKE - FR0010313833 - Euronext Paris
57,650 €  17:35
-2,04 %
15/10/2026 09:00

Inside Information / Other news releases

PRESS RELEASE

Paris la Défense, 15th October 2026

ARKEMA OFFICIALLY OPENS THE EXPANSION OF ITS R&D CENTER IN SHANGHAI

Arkema announces the opening of the expansion of its Shanghai R&D Center, which will take the center to the next level and strengthen its strategic role as an innovation platform serving all the Group’s businesses. The center will enable synergies among teams and co-development with customers in China and across Asia, to accelerate innovation in cutting-edge applications and the successful deployment of advanced and sustainable material solutions. This expansion is fully aligned with the Group’s investment strategy in its global R&D laboratory network.

During his visit in China, Thierry Le Hénaff, Chairman and Chief Executive Officer of Arkema, inaugurated the expanded center alongside the Consul General of France in Shanghai, local government representatives, customers, partners and management representatives.

“China is Arkema’s second-largest market and one of the most dynamic innovation hubs worldwide. As industries and customers in China accelerate their R&D efforts, we must continue to strengthen our local capabilities to stay closely aligned with their evolving needs. This upgrade of Arkema’s R&D Center in Shanghai will bring together expertise from across the Group to co-develop with our customers high performance, sustainable Specialty Materials solutions,” said Thierry Le Hénaff, Chairman and Chief Executive Officer of Arkema.

Arkema’s R&D Center in Shanghai was originally established in 2011 as Bostik’s Asia Technology Center, focused on adhesive solutions. Over the past 15 years, the center has developed strong expertise in materials synthesis, formulation development and application-relevant validation, bringing innovations to markets such as high-speed rail, food packaging and sustainable consumer goods.

This expansion illustrates the One Arkema strategy by leveraging the Group’s broad materials expertise to strengthen its role as a preferred innovation partner. It increases laboratory space by around 20% and adds new collaborative areas, including an interactive showroom, to showcase Arkema’s Specialty Materials solutions and foster closer engagement with customers and partners. This expansion will also reinforce the interactions with the local innovation ecosystem, through partnerships with organizations such as Shanghai Chemical Industrial Park and Green Support Industry (Shanghai) Co., Ltd., which are closely connected to start-ups and emerging technology companies.

In China, the Group will keep on developing its R&D local network in key regions:

  • In the coming 2 months, Arkema will reach a new milestone in the modernization and scaling-up of its battery materials laboratory capabilities, which started earlier this year, at its Changshu R&D Center,
  • Arkema is currently building a One Arkema laboratory in Guangzhou, that will focus on electronics and battery customers.

More globally, Arkema continues to strengthen its innovation capabilities through a particularly dense global R&D network, that combines the expertise developed in China with that of the Group’s research centers in other parts of Asia, in Europe, and in the United States.

Building on its unique set of expertise in materials science, Arkema offers a portfolio of first-class technologies to address ever-growing demand for new and more sustainable materials. With the ambition to become a world leader in Specialty Materials, the Group is structured into three complementary, resilient and highly innovative segments dedicated to Specialty Materials - Adhesive Solutions, Advanced Materials, and Coating Solutions - accounting for some 85% of Group sales in 2025, and a Primary Materials segment regrouping well-positioned large scale industrials activities. Arkema offers cutting-edge technological solutions to meet the challenges of, among other things, new energies, access to water, recycling, urbanization and mobility, and fosters a permanent dialogue with all its stakeholders. The Group reported sales of around €9.1 billion in 2025 and operates in some 55 countries with 20,700 employees worldwide.

Investor relations contacts:

Béatrice Zilm+33 (0)1 49 00 75 58beatrice.zilm@arkema.com
James Poutier+33 (0)1 49 00 73 12james.poutier@arkema.com
Alexis Noël+33 (0)1 49 00 74 37alexis.noel@arkema.com
Franck Zhang+33 (0)1 49 00 72 08franck.zhang@arkema.com

Media Contact:

Anne Plaisance+33 (0)6 81 87 48 77anne.plaisance@arkema.com

Arkema
51, Esplanade du Général de Gaulle CS 10478 - 92907 Paris La Défense – France – T +33 (0)1 49 00 80 80
French Société anonyme, registered at the Trade and Companies Register of Nanterre under
the number 445 074 685
arkema.com

Follow us on:
X.com/Arkema_group
Linkedin.com/company/arkema

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière